Nirav S. Jhaveri insider trades

Open-market stock purchases and sales by Nirav S. Jhaveri, Chief Financial Officer at Opus Genetics, Inc, from SEC Form 4 filings since Feb 12, 2024.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • IRD Opus Genetics, Inc: other filings, last Mar 13, 2025
  • OCUP Ocuphire Pharma, Inc: 1 buy, last Mar 21, 2024

Get free alerts when Nirav S. Jhaveri files a new trade →